Somatotropin
- Generic Name
- Somatotropin
- Brand Names
- Genotropin, Humatrope, Norditropin, Norditropin Nordiflex, Nutropin, Nutropinaq, Omnitrope, Saizen, Serostim, Zomacton, Zorbtive, NutropinAq
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 12629-01-5
- Unique Ingredient Identifier
- NQX9KB6PCL
- Background
Human growth hormone (HGH), also known as somatotropin, is a peptide hormone that is synthesized and secreted by the somatotropic cells of the anterior pituitary gland. Growth hormone plays an essential role in growth regulation during childhood as well as other basal metabolic functions, muscle and fat mass regulation, blood glucose level regulation, and li...
- Indication
Somatotropin is indicated for the treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone, short stature associated with Turner syndrome, Prader-Willi syndrome (PWS), idiopathic short stature (ISS), short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency, and shor...
- Associated Conditions
- Adult Onset Growth Hormone Deficiency, Cachexia, Childhood-onset Growth Hormone Deficiency, Growth Failure, HIV Wasting Syndrome, Short Bowel Syndrome (SBS), Short Stature
- Associated Therapies
- -
Adrenal Function in GHD Children
- Conditions
- Interventions
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2017-06-29
- Lead Sponsor
- University of Palermo
- Target Recruit Count
- 30
- Registration Number
- NCT03203356
- Locations
- 🇮🇹
Endocrinology - University of Palermo, Palermo, Italy
Study of Testosterone and rHGH in FSHD
- Conditions
- Interventions
- First Posted Date
- 2017-04-21
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 20
- Registration Number
- NCT03123913
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Impact of Recombinant Human Growth Hormone on HIV Persistence
- Conditions
- Interventions
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Target Recruit Count
- 22
- Registration Number
- NCT03091374
- Locations
- 🇨🇦
Mcgill University Health Center, Montreal, Quebec, Canada
Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients
- Conditions
- Interventions
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2023-02-13
- Target Recruit Count
- 13
- Registration Number
- NCT03038594
- Locations
- 🇺🇸
University of Texas Medical Branch, Galveston, Texas, United States
Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children
- First Posted Date
- 2017-01-26
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- University of Palermo
- Target Recruit Count
- 32
- Registration Number
- NCT03033121
- Locations
- 🇮🇹
Endocrinology - University of Palermo, Palermo, Italy
The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder
- First Posted Date
- 2017-01-23
- Last Posted Date
- 2017-01-23
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 80
- Registration Number
- NCT03027843
Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
- Conditions
- Interventions
- First Posted Date
- 2017-01-10
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- LG Life Sciences
- Target Recruit Count
- 116
- Registration Number
- NCT03015909
- Locations
- 🇰🇷
Ajou university hospital, Suwon, Gyeong-gi, Korea, Republic of
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
- Conditions
- Interventions
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 224
- Registration Number
- NCT02968004
- Locations
- 🇮🇳
Manipal Hospital, Bengaluru, Karnataka, India
🇨🇳Tri-Service General Hospital, Taipei, Taiwan
🇺🇸University of Massachusettes, Worcester, Massachusetts, United States
Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children
- Conditions
- Interventions
- First Posted Date
- 2016-10-13
- Last Posted Date
- 2016-10-14
- Target Recruit Count
- 24
- Registration Number
- NCT02931591
Lipolytic Effects of GH in Human Subjects in Vivo
- Conditions
- Interventions
- First Posted Date
- 2016-05-25
- Last Posted Date
- 2020-03-26
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 9
- Registration Number
- NCT02782221
- Locations
- 🇩🇰
University Hospital of Aarhus, Aarhus, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.